Therefore, in this study, we evaluated whether treatment in vitro with IL-15 could improve the cytotoxic response in PBMCs of hospitalized individuals with severe and critical COVID-19 as the infection progressed, in order to determine its validity as a candidate to stimulate the immune reconstitution during COVID-19. The gene discussed is IL15; the disease is COVID-19.